Sanofi announced on Monday at the ASCO annual meeting that a combination treatment that includes its anti-CD38 monoclonal antibody Sarclisa had shown a positive effect in reducing disease progression and death in multiple myeloma patients. The news comes as Sanofi pushes for another indication for the drug.
Tag Archive for: disease progression
Topline data from the Phase III PHOENIX trial of Relyvrio, which won approval in 2022, showed no significant difference on either the primary or secondary endpoints, according to Amylyx.
GSK said on that its blood cancer drug Blenrep had reached a key goal in a late-stage trial, as the British drugmaker looks to bolster its oncology business after a series of setbacks.
The findings underscore that “earlier detection and diagnosis can really change the trajectory of this disease,” said Anne White, president of neuroscience at Lilly.